Cannell & Co’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Cannell & Co’s Portfolio YTEN Stock Details YTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$59.5K	Sell	10,338 -447	-4%	-$2.97K	﹤0.01%	261
2023 Q3	$84.6K	Hold	10,785	–	–	﹤0.01%	253
2023 Q2	$575K	Hold	10,785	–	–	0.02%	194
2023 Q1	$714K	Hold	10,785	–	–	0.03%	183
2022 Q4	$427K	Buy	10,785 +4,067	+61%	+$242K	0.02%	212
2022 Q3	$482K	Sell	6,718 -4	-0.1%	-$270	0.02%	202
2022 Q2	$363K	Hold	6,722	–	–	0.01%	227
2022 Q1	$855K	Sell	6,722 -579	-8%	-$59.8K	0.03%	189
2021 Q4	$862K	Sell	7,301 -593	-8%	-$78.2K	0.02%	191
2021 Q3	$1.15M	Hold	7,894	–	–	0.04%	174
2021 Q2	$1.62M	Buy	7,894 +1,250	+19%	+$278K	0.05%	160
2021 Q1	$2M	Buy	6,644 +618	+10%	+$209K	0.06%	141
2020 Q4	$836K	Buy	6,026 +2,146	+55%	+$326K	0.03%	177
2020 Q3	$724K	Buy	3,880 +1,666	+75%	+$246K	0.03%	163
2020 Q2	$333K	Hold	2,214	–	–	0.01%	204
2020 Q1	$200K	Buy	+2,214	New	+$344K	0.01%	210
2019 Q4	–	Sell	-122	Closed	-$59K	–	251
2019 Q3	$59K	Hold	122	–	–	﹤0.01%	235
2019 Q2	$112K	Hold	122	–	–	﹤0.01%	229
2019 Q1	$134K	Hold	122	–	–	0.01%	241
2018 Q4	$97K	Hold	122	–	–	﹤0.01%	237
2018 Q3	$167K	Hold	122	–	–	0.01%	244
2018 Q2	$166K	Hold	122	–	–	0.01%	247
2018 Q1	$229K	Hold	122	–	–	0.01%	233
2017 Q4	$208K	Buy	122 +46	+61%	+$124K	0.01%	240
2017 Q3	$223K	Hold	76	–	–	0.01%	229
2017 Q2	$379K	Sell	76 -4	-5%	-$18.7K	0.01%	211
2017 Q1	$284K	Buy	+80	New	+$284K	0.01%	229
2016 Q4	–	Sell	-80	Closed	-$347K	–	264
2016 Q3	$347K	Hold	80	–	–	0.01%	220
2016 Q2	$640K	Hold	80	–	–	0.02%	189
2016 Q1	$1.46M	Hold	80	–	–	0.05%	151
2015 Q4	$1.17M	Sell	80 -4	-5%	-$80.6K	0.04%	160
2015 Q3	$1.11M	Hold	84	–	–	0.04%	168
2015 Q2	$3.02M	Buy	+84	New	+$3.46M	0.09%	134

Other funds holding YTEN

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cannell & Co's YTEN Position: Q4 2023 in Review

Cannell & Co reduced its Yield10 Bioscience, Inc. Common Stock (YTEN) stake by 4.1% in Q4 2023, selling an estimated $2.97K and leaving 10,338 shares worth $59.5K. The position accounts for ﹤0.01% of the portfolio, ranked #261.

Cannell & Co first reported a position in YTEN in Q2 2015 and has held it in 33 quarters since. The position peaked at $3.02M in Q2 2015. 17 funds tracked by Wall St. Rank hold YTEN as of Q4 2023.

Cannell & Co held 10,338 shares of Yield10 Bioscience, Inc. Common Stock worth $59.5K as of Q4 2023.
Cannell & Co sold 447 Yield10 Bioscience, Inc. Common Stock shares in Q4 2023, an estimated $2.97K.
Yield10 Bioscience, Inc. Common Stock made up ﹤0.01% of Cannell & Co's portfolio in Q4 2023, its #261 holding.
Cannell & Co first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2015 and has held it in 33 quarters since.
Cannell & Co's Yield10 Bioscience, Inc. Common Stock position peaked at $3.02M in Q2 2015.
17 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q4 2023.

Based on Cannell & Co's 13F filing for Q4 2023, filed 5 Feb 2024.